PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.95%
Revenue growth under 50% of ECL.AX's 7.74%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-6.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-42.00%
Negative EBIT growth while ECL.AX is at 20.35%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-42.00%
Negative operating income growth while ECL.AX is at 20.35%. Joel Greenblatt would press for urgent turnaround measures.
94.54%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
50.00%
Positive EPS growth while ECL.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
100.00%
Positive diluted EPS growth while ECL.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
44.17%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
37.23%
Slight or no buyback while ECL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
267.68%
Positive OCF growth while ECL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
290.19%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-77.63%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-47.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-8.54%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
156.32%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
439.03%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
214.30%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
134.43%
Net income/share CAGR at 75-90% of ECL.AX's 167.22%. Bill Ackman would press for strategic moves to boost long-term earnings.
877.36%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
772.00%
3Y net income/share CAGR above 1.5x ECL.AX's 17.65%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18383.98%
Positive short-term equity growth while ECL.AX is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.84%
Firm’s AR is declining while ECL.AX shows 3.97%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-13.53%
Inventory is declining while ECL.AX stands at 0.90%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
16.39%
Positive asset growth while ECL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
22.11%
BV/share growth above 1.5x ECL.AX's 0.83%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
48.69%
Debt growth of 48.69% while ECL.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
100.04%
R&D growth of 100.04% while ECL.AX is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-4.79%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.